Professional
Added to YB: 2025-10-17
Pitch date: 2025-08-31
DXCM [bullish]
DexCom, Inc.
-9.72%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$74.17
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
growth
Bell Global Equities Fund New Position: DexCom, Inc.
DXCM (new position): Leading CGM technology w/ Abbott duopoly, expanding into 25M US type 2 diabetes patients (low single digit penetration targeting teens-25%). International growth opportunity. Sustained double-digit revenue growth, margin expansion driving 20%+ EPS growth.
Read full article (1 min)